坂本 竜弘(サカモト タツヒロ)
- 論文
- Administration of brentuximab vedotin to a Hodgkin lymphoma patient with liver dysfunction due to vanishing bile duct syndrome resulting in a partial response without any severe adverse events
Ishitsuka Kantaro; Yokoyama Yasuhisa; Baba Naoko; Matsuok...
JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY/62(3)/pp.154-157, 2022-07-12 - Cardiac Tamponade as a Recurrence of Angioimmunoblastic T-Cell Lymphoma with the Detection of a p.Gly17Val RHOA Mutation in the Pericardial Effusion
Tsuboi Yuri; Iimura Yumoe; Matsumura Fumiaki; Nanmoku ...
INTERNAL MEDICINE/62(4)/pp.595-600, 2022-06-21 - A Case of Cardiac Tamponade as a Recurrence of Angioimmunoblastic T-Cell Lymphoma with the Detection of a p.Gly17Val RHOA Mutation in the Pericardial Effusion
Tsuboi Yuri; Iimura Yumoe; Matsumura Fumiaki; Nanmoku To...
Internal medicine (Tokyo, Japan), 2022-06-21 - Salvage Cord Blood Transplantation Using a Short-term Reduced-intensity Conditioning Regimen for Graft Failure.
Suma S; Yokoyama Y; Momose H; Makishima K; Kiyoki Y; ...
INTERNAL MEDICINE/61(11)/pp.1673-1679, 2021-11 - A single-cell atlas of non-haematopoietic cells in human lymph nodes and lymphoma reveals a landscape of stromal remodelling
Abe Yoshiaki; Sakata-Yanagimoto Mamiko; Fujisawa Manab...
Nature cell biology/24(4)/pp.565-578, 2022-03 - Tet2 deficiency in immune cells exacerbates tumor progression by increasing angiogenesis in a lung cancer model
Nguyen Yen T M; Fujisawa Manabu; Nguyen Tran B; Suehara ...
Cancer science/112(12)/pp.4931-4943, 2021-10 - Early administration of cyclosporine may reduce the incidence of cytokine release syndrome after HLA-haploidentical hematopoietic stem-cell transplantation with post-transplant cyclophosphamide
Kurita Naoki; Sakamoto Tatsuhiro; Kato Takayasu; Kusakabe...
Annals of hematology/100(5)/pp.1295-1301, 2021-02 - VAV1 mutations contribute to development of T-cell neoplasms in mice
Fukumoto Kota; Sakata-Yanagimoto Mamiko; Fujisawa Mana...
BLOOD/136(26)/pp.3018-3032, 2020-09 - 初回治療としてHLA半合致血縁ドナーから同種造血幹細胞移植を施行した劇症型再生不良性貧血
槇島 健一; 長谷川 雄一; 千葉 滋; 小原 直; 坂本 竜弘; 加藤 貴康; 日下部 学; 錦井 秀和; 栗田...
臨床血液/61(10)/pp.1464-1468, 2020-10 - 地固め療法中に骨髄壊死を発症したフィラデルフィア染色体陽性急性リンパ芽球性白血病
Ishitsuka Kantaro; Obara Naoshi; Suyama Takuya; Matsuoka ...
臨床血液/61(5)/pp.462-467, 2020-05 - Molecular pathogenesis of progression to myeloid leukemia from TET-insufficient status.
R Shrestha; M Sakata-Yanagimoto; K Maie; M Oshima; M Ish...
Blood Adv/4(5)/pp.845-854, 2020-03 - Notch Signaling in Nestin-Expressing Cells in the Bone Marrow Maintains Erythropoiesis via Macrophage Integrity
Sakamoto Tatsuhiro; Obara Naoshi; Nishikii Hidekazu; Kato...
Stem cells (Dayton, Ohio)/37(7)/pp.924-936, 2019-04 - Durable Leukemic Remission and Autologous Marrow Recovery with Random Chromosomal Abnormalities after Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia
Nishikii Hidekazu; Kurita Naoki; Shinagawa Atsushi; Sakam...
CASE REPORTS IN HEMATOLOGY/2019, 2019-01 - The prognosis of disseminated intravascular coagulation associated with hematologic malignancy and its response to recombinant human thrombomodulin
Kurita Naoki; Sakamoto Tatsuhiro; Kato Takayasu; Kusakabe...
Thrombosis research/173/pp.57-64, 2018-11 - An Unprecedented Case of p190 BCR-ABL Chronic Myeloid Leukemia Diagnosed during Treatment for Multiple Myeloma: A Case Report and Review of the Literature
Miki Kosuke; Obara Naoshi; Makishima Kenichi; Sakamoto T...
CASE REPORTS IN HEMATOLOGY/2018/p.7863943, 2018-10 - High efficacy of eculizumab treatment for fulminant hemolytic anemia in primary cold agglutinin disease
Makishima Kenichi; Obara Naoshi; Ishitsuka Kantaro; Sukeg...
Annals of hematology/98(4)/pp.1031-1032, 2018-10 - Liquid biopsy for the identification of intravascular large B-cell lymphoma
Suehara Yasuhito; Sakata-Yanagimoto Mamiko; Hattori Keii...
Haematologica/103(6)/pp.E241-E244, 2018-02 - Effectiveness and safety of rabbit anti-thymocyte globulin in Japanese patients with aplastic anemia
Sakamoto Tatsuhiro; Obara Naoshi; Kurita Naoki; Sakata-Ya...
INTERNATIONAL JOURNAL OF HEMATOLOGY/98(3)/pp.319-322, 2013-09
- Administration of brentuximab vedotin to a Hodgkin lymphoma patient with liver dysfunction due to vanishing bile duct syndrome resulting in a partial response without any severe adverse events